Browse the complete record of transactions filed by Moat Ross, 首席执行官. Officer active across 2 companies, notably Kiniksa Pharmaceuticals, Ltd.. In total, 30 reports have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €596k. History available since 15 July 2021. The latest transaction was filed on 1 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Moat Ross
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
292 股@ US$12.3510.0% 占其流量Class A Common ShareSEC:0001415889-23-013046:0
30 条申报中的 25 条
About Moat Ross
Moat Ross is Directeur Général and serves at Kiniksa Pharmaceuticals International, plc, where he is Chief Operating Officer, and at Kiniksa Pharmaceuticals, Ltd., where he is Chief Commercial Officer. He has filed 25 disclosures in total, and within the 25 recent filings tracked, the amounts show EUR 0 in purchases and EUR 596154 in sales, with activity observed from 2022-03-18 to 2026-04-13, and the most frequent transaction nature being option exercise.